| |
| |
|
| Insider
Information: |
Balo Andrew K |
| Relationship: |
EVP Regulatory Strateg... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
50,908 |
|
|
Indirect Shares
|
30,212 |
|
|
| Direct
Value |
$6,046,343 |
|
|
|
Indirect Value
|
$3,588,279 |
|
|
| Total
Shares |
81,120 |
|
|
| Total
Value |
$9,634,622 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 90.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Regulatory Strateg... |
2023-03-10 |
50,908 |
2023-03-10 |
30,212 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
200 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-12-03 |
4 |
AS |
$86.37 |
$647,781 |
D/D |
(7,500) |
107,680 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-12-03 |
4 |
OE |
$3.19 |
$23,925 |
D/D |
7,500 |
115,180 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-12-17 |
4 |
AS |
$82.52 |
$618,869 |
D/D |
(7,500) |
107,680 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2015-12-17 |
4 |
OE |
$3.19 |
$23,925 |
D/D |
7,500 |
115,180 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-03-08 |
4 |
A |
$0.00 |
$38 |
D/D |
38,000 |
145,777 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-03-10 |
4 |
D |
$63.18 |
$718,230 |
D/D |
(11,368) |
134,409 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-03-14 |
4 |
D |
$63.96 |
$283,348 |
D/D |
(4,430) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-06-20 |
4 |
AS |
$75.00 |
$4,125,000 |
D/D |
(55,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical, Regulatory |
• – – |
2016-06-20 |
4 |
OE |
$3.19 |
$175,450 |
D/D |
55,000 |
184,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-06-29 |
4 |
OE |
$3.19 |
$15,950 |
D/D |
5,000 |
134,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-06-29 |
4 |
AS |
$78.10 |
$390,500 |
D/D |
(5,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-07-13 |
4 |
AS |
$80.12 |
$400,600 |
D/D |
(5,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-07-13 |
4 |
OE |
$3.19 |
$15,950 |
D/D |
5,000 |
134,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-07-27 |
4 |
AS |
$88.14 |
$440,700 |
D/D |
(5,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-07-27 |
4 |
OE |
$3.19 |
$15,950 |
D/D |
5,000 |
134,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-08-10 |
4 |
OE |
$3.19 |
$15,950 |
D/D |
5,000 |
134,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-08-10 |
4 |
AS |
$90.26 |
$451,300 |
D/D |
(5,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-08-24 |
4 |
AS |
$91.72 |
$458,600 |
D/D |
(5,000) |
129,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-08-24 |
4 |
OE |
$3.19 |
$15,950 |
D/D |
5,000 |
134,979 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-09-07 |
4 |
AS |
$94.45 |
$472,156 |
D/D |
(4,999) |
130,010 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-09-07 |
4 |
OE |
$3.19 |
$15,947 |
D/D |
4,999 |
135,009 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-09-09 |
4 |
D |
$93.72 |
$812,387 |
D/D |
(8,668) |
121,342 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-09-21 |
4 |
AS |
$92.87 |
$464,366 |
D/D |
(5,000) |
116,342 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-10-05 |
4 |
AS |
$82.55 |
$412,750 |
D/D |
(5,000) |
111,342 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP, Clinical and Regulatory |
• – – |
2016-10-19 |
4 |
AS |
$82.31 |
$411,303 |
D/D |
(4,997) |
106,345 |
0 |
- |
|
200 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
